Evolent Health, which offers a suite of advisory and technology services to support emerging accountable care organizations, particularly in Medicaid, is paying $145 million in cash and stock to get deeper into the market.

The company has entered a definitive agreement to buy technology vendor Valance Health, which also serves the Medicaid market and brings complementary services to increase scale, as well as new offerings, says Frank Williams, CEO at Evolent Health.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access